Epidermal growth factor receptor and variant III targeted immunotherapy

Immunotherapeutic approaches to cancer have shown remarkable promise. A critical barrier to successfully executing such immune-mediated interventions is the selection of safe yet immunogenic targets. As patient deaths have occurred when tumor-associated antigens shared by normal tissue have been tar...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neuro-oncology (Charlottesville, Va.) Va.), 2014-10, Vol.16 Suppl 8 (suppl 8), p.viii20-viii25
Hauptverfasser:	Congdon, Kendra L, Gedeon, Patrick C, Suryadevara, Carter M, Caruso, Hillary G, Cooper, Laurence J N, Heimberger, Amy B, Sampson, John H
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Brain Neoplasms Cell- and Tissue-Based Therapy Glioma - immunology Glioma - therapy Humans Immunotherapy Invited Reviews Receptor, Epidermal Growth Factor - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!